KANSAS CITY, Kan., March 6, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals, today announced that it will present at two upcoming investor events. Aratana will present at the Barclays Global Healthcare Conference, to be held March 11-13, 2014, in Miami, Florida, and also the Jefferies Animal Health Day, to be held March 27, 2014, in New York City.
Steven St. Peter, M.D., President and Chief Executive Officer, will provide an overview of the Company's business during his live presentations and will be available to participate in one-on-one meetings with investors who are registered to attend the conferences.
Barclays Global Healthcare Conference
Tuesday, March 11, 2014
10:15 am (Eastern Time)
Loews Miami Hotel, Miami Beach, FL
Jefferies Animal Health Day
Thursday, March 27, 2014
10:10 am (Eastern Time)
New York, NY
The presentation at the Barclays Global Healthcare Conference will be webcast live and remain available for 30 days following the presentation. To access the webcast, please visit the investor relations section of the Aratana website at aratana.investorroom.com.
About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.
Tiberend Strategic Advisors, Inc.
Joshua Drumm, Ph.D.
email@example.com; (212) 375-2664
firstname.lastname@example.org; (212) 375-2694
SOURCE Aratana Therapeutics, Inc.